London-based BenevolentAI, which is developing AI tech for drug discovery and more, announces $115M funding round at a $2.1B post-money valuation Ingrid Lunden / TechCrunch : TechCrunch 2018-04-19 Ingrid Lunden 115M, TechCrunch, Ingrid Lunden, London Related Coverage View article ZDNet View article PR Newswire View article Xconomy View article Bloomberg View article SiliconANGLE View article PE Hub Blog